 John Thompson
Concepts (264)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Deep Brain Stimulation | 27 | 2025 | 125 | 10.830 |
Why?
| | Parkinson Disease | 29 | 2025 | 461 | 9.300 |
Why?
| | Subthalamic Nucleus | 15 | 2025 | 67 | 7.590 |
Why?
| | Drug Resistant Epilepsy | 4 | 2024 | 83 | 1.860 |
Why?
| | Epilepsy | 2 | 2025 | 329 | 1.310 |
Why?
| | Globus Pallidus | 3 | 2021 | 23 | 1.290 |
Why?
| | Wakefulness | 4 | 2025 | 120 | 1.290 |
Why?
| | Putamen | 2 | 2020 | 22 | 1.250 |
Why?
| | Sleep Stages | 4 | 2024 | 45 | 1.160 |
Why?
| | Beta Rhythm | 2 | 2024 | 19 | 1.110 |
Why?
| | Basal Ganglia | 3 | 2023 | 53 | 1.100 |
Why?
| | Brain | 6 | 2025 | 2664 | 1.060 |
Why?
| | Brain Waves | 2 | 2017 | 31 | 0.990 |
Why?
| | Sodium Glutamate | 2 | 2016 | 9 | 0.970 |
Why?
| | Sleep | 4 | 2025 | 682 | 0.970 |
Why?
| | Solitary Nucleus | 2 | 2016 | 17 | 0.970 |
Why?
| | Pars Reticulata | 2 | 2022 | 6 | 0.960 |
Why?
| | Pedunculopontine Tegmental Nucleus | 2 | 2016 | 4 | 0.960 |
Why?
| | Electrocorticography | 1 | 2025 | 15 | 0.950 |
Why?
| | Electrodes, Implanted | 7 | 2025 | 105 | 0.920 |
Why?
| | Anterior Thalamic Nuclei | 1 | 2024 | 4 | 0.920 |
Why?
| | Proto-Oncogene Proteins c-fos | 2 | 2016 | 174 | 0.910 |
Why?
| | Seizures | 2 | 2025 | 402 | 0.910 |
Why?
| | Neurons | 9 | 2024 | 1493 | 0.850 |
Why?
| | Thalamus | 3 | 2021 | 94 | 0.840 |
Why?
| | Diffusion Tensor Imaging | 3 | 2021 | 73 | 0.810 |
Why?
| | Methylphenidate | 1 | 2022 | 36 | 0.770 |
Why?
| | Circadian Rhythm | 1 | 2025 | 412 | 0.750 |
Why?
| | Hallucinogens | 1 | 2023 | 91 | 0.720 |
Why?
| | Caudate Nucleus | 1 | 2020 | 20 | 0.690 |
Why?
| | Decision Making | 3 | 2018 | 849 | 0.690 |
Why?
| | Butylated Hydroxytoluene | 2 | 2011 | 38 | 0.660 |
Why?
| | Health Literacy | 1 | 2022 | 161 | 0.660 |
Why?
| | Microelectrodes | 4 | 2024 | 43 | 0.630 |
Why?
| | Middle Aged | 24 | 2025 | 31075 | 0.630 |
Why?
| | Intraoperative Awareness | 1 | 2018 | 2 | 0.600 |
Why?
| | Intraoperative Neurophysiological Monitoring | 2 | 2021 | 21 | 0.600 |
Why?
| | Taste Perception | 2 | 2016 | 25 | 0.580 |
Why?
| | Polysomnography | 5 | 2024 | 161 | 0.570 |
Why?
| | White Matter | 1 | 2019 | 133 | 0.570 |
Why?
| | Male | 36 | 2025 | 63491 | 0.560 |
Why?
| | Humans | 49 | 2025 | 129212 | 0.560 |
Why?
| | Glioma | 2 | 2021 | 354 | 0.530 |
Why?
| | Aged | 18 | 2025 | 22030 | 0.520 |
Why?
| | Cannabis | 1 | 2023 | 445 | 0.500 |
Why?
| | Essential Tremor | 3 | 2024 | 14 | 0.500 |
Why?
| | Space Perception | 1 | 2016 | 76 | 0.500 |
Why?
| | Dystonia | 3 | 2024 | 23 | 0.490 |
Why?
| | Mental Recall | 1 | 2016 | 191 | 0.470 |
Why?
| | Choice Behavior | 1 | 2016 | 165 | 0.470 |
Why?
| | Lac Operon | 1 | 2014 | 45 | 0.460 |
Why?
| | beta-Galactosidase | 1 | 2014 | 76 | 0.460 |
Why?
| | Female | 27 | 2025 | 68600 | 0.450 |
Why?
| | Movement Disorders | 1 | 2014 | 52 | 0.440 |
Why?
| | tau Proteins | 1 | 2014 | 78 | 0.440 |
Why?
| | Neuroma, Acoustic | 2 | 2024 | 41 | 0.420 |
Why?
| | Laser Therapy | 3 | 2021 | 131 | 0.410 |
Why?
| | Dystonic Disorders | 2 | 2024 | 25 | 0.400 |
Why?
| | Tremor | 3 | 2023 | 60 | 0.390 |
Why?
| | Models, Neurological | 1 | 2014 | 242 | 0.390 |
Why?
| | Magnetic Resonance Imaging | 5 | 2024 | 3390 | 0.380 |
Why?
| | Hypokinesia | 2 | 2022 | 8 | 0.360 |
Why?
| | Xenobiotics | 1 | 2011 | 29 | 0.360 |
Why?
| | Cannabinoid Receptor Modulators | 1 | 2010 | 8 | 0.360 |
Why?
| | Finches | 1 | 2010 | 12 | 0.360 |
Why?
| | Vocalization, Animal | 1 | 2010 | 31 | 0.350 |
Why?
| | Oxidants | 1 | 2011 | 109 | 0.350 |
Why?
| | Pilot Projects | 3 | 2025 | 1584 | 0.350 |
Why?
| | Endocannabinoids | 1 | 2010 | 45 | 0.350 |
Why?
| | Glutamic Acid | 1 | 2010 | 236 | 0.310 |
Why?
| | Neuronal Plasticity | 1 | 2010 | 272 | 0.300 |
Why?
| | Alcohol Oxidoreductases | 1 | 2008 | 58 | 0.290 |
Why?
| | Action Potentials | 3 | 2024 | 485 | 0.290 |
Why?
| | Carcinogens | 1 | 2008 | 110 | 0.290 |
Why?
| | Learning | 1 | 2010 | 399 | 0.260 |
Why?
| | Electroencephalography | 2 | 2025 | 400 | 0.250 |
Why?
| | Trapezoid Body | 2 | 2016 | 9 | 0.250 |
Why?
| | Implantable Neurostimulators | 1 | 2025 | 8 | 0.240 |
Why?
| | Adult | 11 | 2025 | 35464 | 0.240 |
Why?
| | Motor Activity | 3 | 2021 | 676 | 0.240 |
Why?
| | Animals | 14 | 2022 | 35219 | 0.240 |
Why?
| | Superior Colliculi | 2 | 2015 | 37 | 0.240 |
Why?
| | Actigraphy | 1 | 2025 | 98 | 0.230 |
Why?
| | Cavernous Sinus | 1 | 2024 | 17 | 0.230 |
Why?
| | Enzyme Inhibitors | 1 | 2008 | 826 | 0.230 |
Why?
| | Antioxidants | 1 | 2008 | 557 | 0.230 |
Why?
| | Pneumocephalus | 1 | 2024 | 3 | 0.220 |
Why?
| | Young Adult | 4 | 2025 | 12396 | 0.220 |
Why?
| | Treatment Outcome | 9 | 2024 | 10189 | 0.210 |
Why?
| | Mice, Transgenic | 4 | 2016 | 2111 | 0.210 |
Why?
| | Mice, Inbred C57BL | 5 | 2021 | 5408 | 0.210 |
Why?
| | Taste | 2 | 2016 | 215 | 0.210 |
Why?
| | Ear, Inner | 1 | 2023 | 44 | 0.210 |
Why?
| | Cannabinoid Receptor Agonists | 1 | 2023 | 38 | 0.200 |
Why?
| | Reward | 2 | 2016 | 237 | 0.200 |
Why?
| | Proof of Concept Study | 1 | 2022 | 68 | 0.200 |
Why?
| | Observer Variation | 1 | 2023 | 314 | 0.200 |
Why?
| | Cannabidiol | 1 | 2024 | 99 | 0.190 |
Why?
| | Intralaminar Thalamic Nuclei | 1 | 2022 | 13 | 0.190 |
Why?
| | Tertiary Care Centers | 1 | 2023 | 151 | 0.190 |
Why?
| | Dronabinol | 1 | 2024 | 190 | 0.190 |
Why?
| | Substantia Nigra | 1 | 2022 | 56 | 0.190 |
Why?
| | Skull Base | 2 | 2020 | 43 | 0.190 |
Why?
| | Mice | 8 | 2021 | 16861 | 0.190 |
Why?
| | Psychosurgery | 1 | 2021 | 8 | 0.190 |
Why?
| | Upper Extremity | 1 | 2022 | 92 | 0.190 |
Why?
| | Zona Incerta | 1 | 2021 | 3 | 0.180 |
Why?
| | Anesthesia, General | 1 | 2021 | 53 | 0.180 |
Why?
| | Craniotomy | 1 | 2021 | 68 | 0.180 |
Why?
| | Neurosurgical Procedures | 2 | 2024 | 173 | 0.180 |
Why?
| | Conscious Sedation | 1 | 2021 | 84 | 0.180 |
Why?
| | Anticonvulsants | 1 | 2023 | 209 | 0.180 |
Why?
| | Retrospective Studies | 7 | 2024 | 14488 | 0.170 |
Why?
| | Consensus | 1 | 2023 | 612 | 0.170 |
Why?
| | Atrophy | 1 | 2020 | 170 | 0.170 |
Why?
| | Robotic Surgical Procedures | 1 | 2021 | 109 | 0.160 |
Why?
| | Biomechanical Phenomena | 1 | 2022 | 763 | 0.160 |
Why?
| | Extracellular Vesicles | 1 | 2021 | 130 | 0.160 |
Why?
| | Evoked Potentials, Auditory | 1 | 2020 | 179 | 0.150 |
Why?
| | Neoplasm Grading | 1 | 2019 | 285 | 0.150 |
Why?
| | Psychoacoustics | 1 | 2018 | 10 | 0.150 |
Why?
| | Intraoperative Period | 1 | 2018 | 53 | 0.150 |
Why?
| | Corpus Striatum | 1 | 2020 | 159 | 0.150 |
Why?
| | Reproducibility of Results | 2 | 2023 | 3067 | 0.150 |
Why?
| | Lung | 1 | 2011 | 3916 | 0.150 |
Why?
| | Behavior, Animal | 1 | 2021 | 506 | 0.140 |
Why?
| | Psychotic Disorders | 1 | 2020 | 151 | 0.140 |
Why?
| | Brain Mapping | 1 | 2021 | 572 | 0.140 |
Why?
| | Neuropsychological Tests | 1 | 2022 | 1006 | 0.140 |
Why?
| | Algorithms | 1 | 2025 | 1618 | 0.140 |
Why?
| | Orientation | 2 | 2015 | 44 | 0.140 |
Why?
| | Epilepsy, Temporal Lobe | 1 | 2017 | 28 | 0.130 |
Why?
| | REM Sleep Behavior Disorder | 1 | 2016 | 14 | 0.130 |
Why?
| | Mice, Inbred BALB C | 2 | 2011 | 1243 | 0.130 |
Why?
| | Biomarkers | 2 | 2025 | 3968 | 0.130 |
Why?
| | Acoustic Stimulation | 1 | 2018 | 328 | 0.130 |
Why?
| | Stereotaxic Techniques | 1 | 2016 | 38 | 0.130 |
Why?
| | Referral and Consultation | 1 | 2022 | 731 | 0.130 |
Why?
| | Brain Injuries | 1 | 2021 | 467 | 0.130 |
Why?
| | Grape Seed Extract | 2 | 2013 | 44 | 0.130 |
Why?
| | Imaging, Three-Dimensional | 1 | 2019 | 530 | 0.130 |
Why?
| | Drinking | 1 | 2016 | 38 | 0.130 |
Why?
| | Cadaver | 3 | 2024 | 306 | 0.130 |
Why?
| | Neoplasm Staging | 1 | 2019 | 1292 | 0.130 |
Why?
| | Vision Disorders | 1 | 2017 | 135 | 0.120 |
Why?
| | Cues | 1 | 2018 | 326 | 0.120 |
Why?
| | Amygdala | 1 | 2017 | 196 | 0.120 |
Why?
| | Odorants | 1 | 2016 | 147 | 0.120 |
Why?
| | Image Processing, Computer-Assisted | 1 | 2019 | 742 | 0.120 |
Why?
| | Anxiety | 1 | 2022 | 959 | 0.120 |
Why?
| | Stimulation, Chemical | 1 | 2014 | 63 | 0.120 |
Why?
| | Dyskinesias | 1 | 2014 | 19 | 0.120 |
Why?
| | Acetylcholine | 1 | 2015 | 185 | 0.110 |
Why?
| | Synapses | 2 | 2016 | 391 | 0.110 |
Why?
| | Staining and Labeling | 1 | 2014 | 141 | 0.110 |
Why?
| | Psychometrics | 1 | 2018 | 684 | 0.110 |
Why?
| | Optogenetics | 1 | 2015 | 112 | 0.110 |
Why?
| | Membrane Potentials | 1 | 2014 | 291 | 0.110 |
Why?
| | Anthocyanins | 1 | 2013 | 31 | 0.110 |
Why?
| | Schizophrenia | 1 | 2017 | 431 | 0.110 |
Why?
| | Symptom Assessment | 1 | 2014 | 125 | 0.110 |
Why?
| | Neural Inhibition | 1 | 2014 | 155 | 0.100 |
Why?
| | Cytokines | 1 | 2021 | 2011 | 0.100 |
Why?
| | Stroke | 1 | 2021 | 1064 | 0.100 |
Why?
| | Locomotion | 1 | 2013 | 100 | 0.100 |
Why?
| | Equipment Design | 1 | 2014 | 513 | 0.100 |
Why?
| | Task Performance and Analysis | 1 | 2013 | 173 | 0.100 |
Why?
| | Smell | 1 | 2013 | 132 | 0.100 |
Why?
| | Receptors, Androgen | 1 | 2013 | 147 | 0.100 |
Why?
| | STAT3 Transcription Factor | 1 | 2013 | 195 | 0.100 |
Why?
| | Biflavonoids | 1 | 2011 | 9 | 0.100 |
Why?
| | Proanthocyanidins | 1 | 2011 | 10 | 0.090 |
Why?
| | Glucuronides | 1 | 2011 | 18 | 0.090 |
Why?
| | Hippocampus | 1 | 2017 | 856 | 0.090 |
Why?
| | Microsomes, Liver | 1 | 2011 | 86 | 0.090 |
Why?
| | Catechin | 1 | 2011 | 24 | 0.090 |
Why?
| | Nerve Net | 1 | 2014 | 259 | 0.090 |
Why?
| | Reactive Nitrogen Species | 1 | 2011 | 22 | 0.090 |
Why?
| | Glutathione Transferase | 1 | 2011 | 101 | 0.090 |
Why?
| | Antineoplastic Agents, Phytogenic | 1 | 2011 | 187 | 0.090 |
Why?
| | Endoscopy | 2 | 2024 | 270 | 0.090 |
Why?
| | Dendritic Spines | 1 | 2010 | 64 | 0.080 |
Why?
| | NF-kappa B | 1 | 2013 | 653 | 0.080 |
Why?
| | Time Factors | 1 | 2020 | 6549 | 0.080 |
Why?
| | Glutathione | 1 | 2011 | 348 | 0.080 |
Why?
| | Alkylation | 1 | 2008 | 24 | 0.080 |
Why?
| | Synaptic Transmission | 1 | 2010 | 269 | 0.080 |
Why?
| | Adolescent | 2 | 2025 | 20371 | 0.080 |
Why?
| | Reactive Oxygen Species | 1 | 2011 | 595 | 0.070 |
Why?
| | Cytosol | 1 | 2008 | 218 | 0.070 |
Why?
| | Spectrometry, Mass, Electrospray Ionization | 1 | 2008 | 178 | 0.070 |
Why?
| | Lung Neoplasms | 2 | 2011 | 2339 | 0.070 |
Why?
| | Chromatography, High Pressure Liquid | 1 | 2008 | 575 | 0.060 |
Why?
| | Neural Pathways | 2 | 2020 | 302 | 0.060 |
Why?
| | Diphosphonates | 1 | 2006 | 56 | 0.060 |
Why?
| | Disease Models, Animal | 2 | 2021 | 4049 | 0.060 |
Why?
| | Recombinant Proteins | 1 | 2008 | 1303 | 0.060 |
Why?
| | Sella Turcica | 1 | 2024 | 16 | 0.060 |
Why?
| | Neuroendoscopy | 1 | 2024 | 19 | 0.060 |
Why?
| | Apoptosis | 1 | 2013 | 2501 | 0.060 |
Why?
| | Patch-Clamp Techniques | 2 | 2016 | 275 | 0.060 |
Why?
| | Biomarkers, Tumor | 1 | 2011 | 1181 | 0.060 |
Why?
| | Facial Nerve | 1 | 2024 | 33 | 0.060 |
Why?
| | Diffusion Magnetic Resonance Imaging | 1 | 2024 | 96 | 0.050 |
Why?
| | Edema | 1 | 2023 | 124 | 0.050 |
Why?
| | Mitochondria | 1 | 2008 | 875 | 0.050 |
Why?
| | Oxidopamine | 1 | 2021 | 13 | 0.050 |
Why?
| | Adrenergic Agents | 1 | 2021 | 6 | 0.050 |
Why?
| | Parkinson Disease, Secondary | 1 | 2021 | 7 | 0.050 |
Why?
| | Evoked Potentials, Motor | 1 | 2021 | 40 | 0.050 |
Why?
| | Immunohistochemistry | 2 | 2016 | 1696 | 0.050 |
Why?
| | Corpus Callosum | 1 | 2021 | 66 | 0.050 |
Why?
| | Sleep Wake Disorders | 1 | 2024 | 252 | 0.050 |
Why?
| | Electric Impedance | 1 | 2020 | 101 | 0.040 |
Why?
| | Nose | 1 | 2020 | 63 | 0.040 |
Why?
| | Fingers | 1 | 2020 | 86 | 0.040 |
Why?
| | Double-Blind Method | 1 | 2024 | 1871 | 0.040 |
Why?
| | Melanoma | 1 | 2006 | 729 | 0.040 |
Why?
| | Movement | 1 | 2020 | 269 | 0.040 |
Why?
| | Meningioma | 1 | 2018 | 81 | 0.030 |
Why?
| | Dreams | 1 | 2016 | 11 | 0.030 |
Why?
| | Meningeal Neoplasms | 1 | 2018 | 93 | 0.030 |
Why?
| | Visual Pathways | 1 | 2017 | 50 | 0.030 |
Why?
| | Surgery, Computer-Assisted | 1 | 2017 | 76 | 0.030 |
Why?
| | Visual Fields | 1 | 2017 | 87 | 0.030 |
Why?
| | Synaptosomal-Associated Protein 25 | 1 | 2016 | 26 | 0.030 |
Why?
| | Gerbillinae | 1 | 2016 | 64 | 0.030 |
Why?
| | Spinal Cord | 1 | 2018 | 356 | 0.030 |
Why?
| | Spatial Behavior | 1 | 2015 | 26 | 0.030 |
Why?
| | Fluorescence | 1 | 2015 | 159 | 0.030 |
Why?
| | Exploratory Behavior | 1 | 2015 | 89 | 0.030 |
Why?
| | Glycine Plasma Membrane Transport Proteins | 1 | 2014 | 5 | 0.030 |
Why?
| | Microscopy, Fluorescence | 1 | 2016 | 400 | 0.030 |
Why?
| | Rhodamines | 1 | 2014 | 18 | 0.030 |
Why?
| | Cholera Toxin | 1 | 2014 | 31 | 0.030 |
Why?
| | Antineoplastic Agents | 1 | 2006 | 2058 | 0.030 |
Why?
| | Heterocyclic Compounds, 3-Ring | 1 | 2014 | 31 | 0.030 |
Why?
| | Electroporation | 1 | 2014 | 37 | 0.030 |
Why?
| | Photic Stimulation | 1 | 2015 | 241 | 0.030 |
Why?
| | Lysine | 1 | 2016 | 286 | 0.030 |
Why?
| | Glutamate Decarboxylase | 1 | 2014 | 166 | 0.030 |
Why?
| | Single-Cell Analysis | 1 | 2016 | 276 | 0.030 |
Why?
| | Case-Control Studies | 1 | 2021 | 3372 | 0.030 |
Why?
| | Electric Stimulation | 1 | 2014 | 268 | 0.030 |
Why?
| | Functional Laterality | 1 | 2014 | 219 | 0.030 |
Why?
| | Prognosis | 1 | 2021 | 3791 | 0.030 |
Why?
| | Green Fluorescent Proteins | 1 | 2014 | 385 | 0.030 |
Why?
| | Brain Neoplasms | 1 | 2021 | 1170 | 0.020 |
Why?
| | Postoperative Complications | 1 | 2024 | 2476 | 0.020 |
Why?
| | In Vitro Techniques | 1 | 2014 | 1083 | 0.020 |
Why?
| | Animals, Newborn | 1 | 2014 | 826 | 0.020 |
Why?
| | Dimerization | 1 | 2011 | 191 | 0.020 |
Why?
| | Methylation | 1 | 2011 | 230 | 0.020 |
Why?
| | Palliative Care | 1 | 2017 | 718 | 0.020 |
Why?
| | Quality of Life | 1 | 2022 | 2693 | 0.020 |
Why?
| | Cell Survival | 1 | 2013 | 1085 | 0.020 |
Why?
| | Prospective Studies | 1 | 2021 | 7103 | 0.020 |
Why?
| | Severity of Illness Index | 1 | 2016 | 2736 | 0.020 |
Why?
| | Follow-Up Studies | 1 | 2017 | 4886 | 0.020 |
Why?
| | Age Factors | 1 | 2014 | 3137 | 0.020 |
Why?
| | Cell Line, Tumor | 1 | 2013 | 3211 | 0.020 |
Why?
| | Cell Proliferation | 1 | 2013 | 2388 | 0.020 |
Why?
| | Prostatic Neoplasms | 1 | 2013 | 1016 | 0.020 |
Why?
| | Aged, 80 and over | 1 | 2006 | 7061 | 0.010 |
Why?
|
|
Thompson's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|